Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

CF | Complete CF Industries Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.